Related Experiment Video
Updated: Jul 8, 2026
07:25
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Matrix metalloproteinases in critical limb ischemia.
Mark J Hobeika1, Rachel S Edlin, Bart E Muhs
1Department of Surgery, New York University School of Medicine, New York, New York, USA.
The Journal of Surgical Research
|December 25, 2007
Summary
Critical limb ischemia (CLI) involves arterial blockages and reperfusion. Matrix metalloproteinases (MMPs) are key enzymes influencing both arterial occlusion and the limb reperfusion processes in CLI.
Area of Science:
- Vascular biology
- Biochemistry
- Medical research
Background:
- Critical limb ischemia (CLI) often stems from atherosclerotic disease in infrainguinal arteries.
- The body attempts to restore blood flow through angiogenesis and arteriogenesis.
Purpose of the Study:
- To review the literature on the role of matrix metalloproteinases (MMPs) in CLI.
- To summarize MMP functions in arterial occlusion and limb reperfusion.
Main Methods:
- Literature review of recent studies.
- Analysis of MMP involvement in atherosclerosis, angiogenesis, and arteriogenesis.
Main Results:
- Matrix metalloproteinases (MMPs) are crucial extracellular matrix-remodeling enzymes.
- MMPs play significant roles in both the development of arterial occlusive disease and the subsequent reperfusion processes in CLI.
Conclusions:
- MMPs are integral to the pathophysiology of critical limb ischemia.
- Understanding MMP functions is vital for potential therapeutic strategies targeting CLI.
